{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:34:18Z","timestamp":1784140458631,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["MS 130053"],"award-info":[{"award-number":["MS 130053"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11481-019-09894-7","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T12:55:28Z","timestamp":1576068928000},"page":"249-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Roslynn E.","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan G.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve E.","family":"Kelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4167-2271","authenticated-orcid":false,"given":"Brett T.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"9894_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","volume":"23","author":"MJ Acuna","year":"2014","unstructured":"Acuna MJ et al (2014) Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling. Hum Mol Genet 23:1237\u20131249. https:\/\/doi.org\/10.1093\/hmg\/ddt514","journal-title":"Hum Mol Genet"},{"key":"9894_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11906-014-0429-9","volume":"16","author":"S Ahmad","year":"2014","unstructured":"Ahmad S, Varagic J, Groban L, Dell\u2019Italia LJ, Nagata S, Kon ND, Ferrario CM (2014) Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate. Curr Hypertens Rep 16:429. https:\/\/doi.org\/10.1007\/s11906-014-0429-9","journal-title":"Curr Hypertens Rep"},{"key":"9894_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0361-9230(98)00039-2","volume":"47","author":"AM Allen","year":"1998","unstructured":"Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, Mendelsohn FA (1998) Angiotensin receptors in the nervous system. Brain Res Bull 47:17\u201328","journal-title":"Brain Res Bull"},{"key":"9894_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","volume":"465","author":"M Bader","year":"2013","unstructured":"Bader M (2013) ACE2, angiotensin-(1-7), and Mas: the other side of the coin. Pflugers Arch 465:79\u201385","journal-title":"Pflugers Arch"},{"key":"9894_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11906-014-0512-2","volume":"17","author":"DM Bennion","year":"2015","unstructured":"Bennion DM, Haltigan E, Regenhardt RW, Steckelings UM, Sumners C (2015) Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke. Curr Hypertens Rep 17:3. https:\/\/doi.org\/10.1007\/s11906-014-0512-2","journal-title":"Curr Hypertens Rep"},{"key":"9894_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","volume":"206","author":"C Bjartmar","year":"2003","unstructured":"Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165\u2013171","journal-title":"J Neurol Sci"},{"key":"9894_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1155\/2013\/102602","volume":"2013","author":"VL Bodiga","year":"2013","unstructured":"Bodiga VL, Bodiga S (2013) Renin angiotensin system in cognitive function and dementia. Asian J Neurosci 2013:18. https:\/\/doi.org\/10.1155\/2013\/102602","journal-title":"Asian J Neurosci"},{"key":"9894_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/CS20110036","volume":"121","author":"S Bosnyak","year":"2011","unstructured":"Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, Widdop RE (2011) Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) 121:297\u2013303. https:\/\/doi.org\/10.1042\/CS20110036","journal-title":"Clin Sci (Lond)"},{"key":"9894_CR9","first-page":"554","volume":"41","author":"JM Charcot","year":"1868","unstructured":"Charcot JM (1868) Histologie de la sclerose en plaques. La Lancette Fran\u00e7aise Gazette des Hopitaux Civil et Militaires 41:554","journal-title":"La Lancette Fran\u00e7aise Gazette des Hopitaux Civil et Militaires"},{"key":"9894_CR10","first-page":"171","volume":"109","author":"A Ciobica","year":"2009","unstructured":"Ciobica A, Bild W, Hritcu L, Haulica I (2009) Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia. Acta Neurol Belg 109:171\u2013180","journal-title":"Acta Neurol Belg"},{"key":"9894_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"9894_CR12","doi-asserted-by":"publisher","first-page":"R444","DOI":"10.1152\/ajpregu.00078.2015","volume":"309","author":"AD de Kloet","year":"2015","unstructured":"de Kloet AD, Liu M, Rodriguez V, Krause EG, Sumners C (2015) Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control. Am J Physiol Regul Integr Comp Physiol 309:R444\u2013R458. https:\/\/doi.org\/10.1152\/ajpregu.00078.2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9894_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","volume":"30","author":"CM Ferrario","year":"1997","unstructured":"Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI (1997) Counterregulatory actions of angiotensin-(1-7). Hypertension 30:535\u2013541","journal-title":"Hypertension"},{"key":"9894_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175\u20131189. https:\/\/doi.org\/10.1093\/brain\/awp070","journal-title":"Brain"},{"key":"9894_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20120652","volume":"125","author":"MM Gironacci","year":"2013","unstructured":"Gironacci MM, Longo Carbajosa NA, Goldstein J, Cerrato BD (2013) Neuromodulatory role of angiotensin-(1-7) in the central nervous system. Clin Sci (Lond) 125:57\u201365. https:\/\/doi.org\/10.1042\/CS20120652","journal-title":"Clin Sci (Lond)"},{"key":"9894_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-444-52001-2.00010-8","volume":"122","author":"DS Goodin","year":"2014","unstructured":"Goodin DS (2014) The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol 122:231\u2013266. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00010-8","journal-title":"Handb Clin Neurol"},{"key":"9894_CR17","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.ajpath.2017.08.012","volume":"187","author":"X Guo","year":"2017","unstructured":"Guo X, Namekata K, Kimura A, Harada C, Harada T (2017) The renin-angiotensin system regulates neurodegeneration in a mouse model of optic neuritis. Am J Pathol 187:2876\u20132885. https:\/\/doi.org\/10.1016\/j.ajpath.2017.08.012","journal-title":"Am J Pathol"},{"key":"9894_CR18","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.1073\/pnas.1612668113","volume":"113","author":"A Hammer","year":"2016","unstructured":"Hammer A et al (2016) Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A 113:14109\u201314114. https:\/\/doi.org\/10.1073\/pnas.1612668113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9894_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1570159X11311020007","volume":"11","author":"T Jiang","year":"2013","unstructured":"Jiang T, Gao L, Lu J, Zhang YD (2013a) ACE2-Ang-(1-7)-Mas axis in brain: a potential target for prevention and treatment of ischemic stroke. Curr Neuropharmacol 11:209\u2013217. https:\/\/doi.org\/10.2174\/1570159X11311020007","journal-title":"Curr Neuropharmacol"},{"key":"9894_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2012.10.014","volume":"67","author":"T Jiang","year":"2013","unstructured":"Jiang T, Gao L, Shi J, Lu J, Wang Y, Zhang Y (2013b) Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol Res 67:84\u201393. https:\/\/doi.org\/10.1016\/j.phrs.2012.10.014","journal-title":"Pharmacol Res"},{"key":"9894_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1352458508097923","volume":"15","author":"M Kawajiri","year":"2009","unstructured":"Kawajiri M et al (2009) Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis. Mult Scler 15:262\u2013265. https:\/\/doi.org\/10.1177\/1352458508097923","journal-title":"Mult Scler"},{"key":"9894_CR22","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","volume":"111","author":"E Kostenis","year":"2005","unstructured":"Kostenis E et al (2005) G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111:1806\u20131813. https:\/\/doi.org\/10.1161\/01.CIR.0000160867.23556.7D","journal-title":"Circulation"},{"key":"9894_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Bruck W, Lassmann H (2017) An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 133:13\u201324. https:\/\/doi.org\/10.1007\/s00401-016-1653-y","journal-title":"Acta Neuropathol"},{"key":"9894_CR24","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1172\/JCI41709","volume":"120","author":"TV Lanz","year":"2010","unstructured":"Lanz TV et al (2010) Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest 120:2782\u20132794. https:\/\/doi.org\/10.1172\/JCI41709","journal-title":"J Clin Invest"},{"key":"9894_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.npep.2013.09.002","volume":"47","author":"J Lu","year":"2013","unstructured":"Lu J et al (2013) The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides 47:289\u2013295. https:\/\/doi.org\/10.1016\/j.npep.2013.09.002","journal-title":"Neuropeptides"},{"key":"9894_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2019.02.018","volume":"127","author":"BT Lund","year":"2019","unstructured":"Lund BT et al (2019) Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis. Neurobiol Dis 127:87\u2013100. https:\/\/doi.org\/10.1016\/j.nbd.2019.02.018","journal-title":"Neurobiol Dis"},{"key":"9894_CR27","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/bph.13057","volume":"172","author":"GS Magalhaes","year":"2015","unstructured":"Magalhaes GS et al (2015) Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol 172:2330\u20132342. https:\/\/doi.org\/10.1111\/bph.13057","journal-title":"Br J Pharmacol"},{"key":"9894_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.peptides.2011.11.014","volume":"33","author":"EG Mario","year":"2012","unstructured":"Mario EG, Santos SH, Ferreira AV, Bader M, Santos RA, Botion LM (2012) Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes. Peptides 33:174\u2013177. https:\/\/doi.org\/10.1016\/j.peptides.2011.11.014","journal-title":"Peptides"},{"key":"9894_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1357-2725(02)00306-0","volume":"35","author":"MJ McKinley","year":"2003","unstructured":"McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen R, Oldfield BJ, Mendelsohn FA, Chai SY (2003) The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35:901\u2013918","journal-title":"Int J Biochem Cell Biol"},{"key":"9894_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1447-0594.2012.00900.x","volume":"13","author":"M Mogi","year":"2013","unstructured":"Mogi M, Horiuchi M (2013) Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases. Geriatr Gerontol Int 13:13\u201318. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00900.x","journal-title":"Geriatr Gerontol Int"},{"key":"9894_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2012.11.008","volume":"51","author":"P Namsolleck","year":"2013","unstructured":"Namsolleck P et al (2013) AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol Dis 51:177\u2013191. https:\/\/doi.org\/10.1016\/j.nbd.2012.11.008","journal-title":"Neurobiol Dis"},{"key":"9894_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/HJH.0000000000000094","volume":"32","author":"MP Ocaranza","year":"2014","unstructured":"Ocaranza MP et al (2014) Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme\/Ang II axis. J Hypertens 32:771\u2013783. https:\/\/doi.org\/10.1097\/HJH.0000000000000094","journal-title":"J Hypertens"},{"key":"9894_CR33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.imbio.2015.07.013","volume":"220","author":"OC Oliveira-Lima","year":"2015","unstructured":"Oliveira-Lima OC et al (2015) Mas receptor deficiency exacerbates lipopolysaccharide-induced cerebral and systemic inflammation in mice. Immunobiology 220:1311\u20131321. https:\/\/doi.org\/10.1016\/j.imbio.2015.07.013","journal-title":"Immunobiology"},{"key":"9894_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/CS20120461","volume":"124","author":"DG Passos-Silva","year":"2013","unstructured":"Passos-Silva DG, Verano-Braga T, Santos RA (2013) Angiotensin-(1-7): beyond the cardio-renal actions. Clin Sci (Lond) 124:443\u2013456. https:\/\/doi.org\/10.1042\/CS20120461","journal-title":"Clin Sci (Lond)"},{"key":"9894_CR35","doi-asserted-by":"publisher","first-page":"14948","DOI":"10.1073\/pnas.0903958106","volume":"106","author":"M Platten","year":"2009","unstructured":"Platten M et al (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A 106:14948\u201314953. https:\/\/doi.org\/10.1073\/pnas.0903958106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9894_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini C, De Rosa V, Pucino V, Formisano L, Matarese G (2015) Animal models of multiple sclerosis. Eur J Pharmacol 759:182\u2013191. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.042","journal-title":"Eur J Pharmacol"},{"key":"9894_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jash.2008.05.003","volume":"2","author":"LA Rabelo","year":"2008","unstructured":"Rabelo LA, Xu P, Todiras M, Sampaio WO, Buttgereit J, Bader M, Santos RA, Alenina N (2008) Ablation of angiotensin (1-7) receptor Mas in C57Bl\/6 mice causes endothelial dysfunction. J Am Soc Hypertens 2:418\u2013424. https:\/\/doi.org\/10.1016\/j.jash.2008.05.003","journal-title":"J Am Soc Hypertens"},{"key":"9894_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2013.06.008","volume":"45","author":"M Rangachari","year":"2013","unstructured":"Rangachari M, Kuchroo VK (2013) Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun 45:31\u201339. https:\/\/doi.org\/10.1016\/j.jaut.2013.06.008","journal-title":"J Autoimmun"},{"key":"9894_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuropharm.2013.03.025","volume":"71","author":"RW Regenhardt","year":"2013","unstructured":"Regenhardt RW, Desland F, Mecca AP, Pioquinto DJ, Afzal A, Mocco J, Sumners C (2013) Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 71:154\u2013163. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.03.025","journal-title":"Neuropharmacology"},{"key":"9894_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","volume":"383","author":"GI Rice","year":"2004","unstructured":"Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383:45\u201351. https:\/\/doi.org\/10.1042\/BJ20040634","journal-title":"Biochem J"},{"key":"9894_CR41","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RA Santos","year":"2003","unstructured":"Santos RA et al (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100:8258\u20138263. https:\/\/doi.org\/10.1073\/pnas.1432869100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9894_CR42","doi-asserted-by":"publisher","first-page":"14942","DOI":"10.1073\/pnas.0903602106","volume":"106","author":"J Stegbauer","year":"2009","unstructured":"Stegbauer J et al (2009) Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci U S A 106:14942\u201314947. https:\/\/doi.org\/10.1073\/pnas.0903602106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9894_CR43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/1440-1681.12137","volume":"40","author":"C Sumners","year":"2013","unstructured":"Sumners C, Horiuchi M, Widdop RE, McCarthy C, Unger T, Steckelings UM (2013) Protective arms of the renin-angiotensin-system in neurological disease. Clin Exp Pharmacol Physiol 40:580\u2013588. https:\/\/doi.org\/10.1111\/1440-1681.12137","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9894_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247\u2013269. https:\/\/doi.org\/10.1146\/annurev.neuro.30.051606.094313","journal-title":"Annu Rev Neurosci"},{"key":"9894_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20130601","volume":"128","author":"V Valero-Esquitino","year":"2015","unstructured":"Valero-Esquitino V et al (2015) Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice. Clin Sci (Lond) 128:95\u2013109. https:\/\/doi.org\/10.1042\/CS20130601","journal-title":"Clin Sci (Lond)"},{"key":"9894_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","volume":"465","author":"JW Wright","year":"2013","unstructured":"Wright JW, Harding JW (2013) The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch 465:133\u2013151. https:\/\/doi.org\/10.1007\/s00424-012-1102-2","journal-title":"Pflugers Arch"},{"key":"9894_CR47","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/HYPERTENSIONAHA.107.102764","volume":"51","author":"P Xu","year":"2008","unstructured":"Xu P et al (2008) Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension 51:574\u2013580. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.102764","journal-title":"Hypertension"},{"key":"9894_CR48","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.3892\/etm.2015.2801","volume":"10","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Qin Y, Liu T, Hao D (2015) Chronic nerve injury-induced Mas receptor expression in dorsal root ganglion neurons alleviates neuropathic pain. Exp Ther Med 10:2384\u20132388. https:\/\/doi.org\/10.3892\/etm.2015.2801","journal-title":"Exp Ther Med"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-019-09894-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T01:44:13Z","timestamp":1607564653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-019-09894-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9894"],"URL":"https:\/\/doi.org\/10.1007\/s11481-019-09894-7","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This animal study was performed in accordance with ethical and humane standards set forth by the National Institutes of Health, and with the approval of University of Southern California\u2019s Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All of the authors of this manuscript declare no conflict of interest. Dr. Lund has however received investigator-initiated funding from Teva Pharmaceutical Industries, Novartis Pharmaceuticals Corporation and Sanofi-Genzyme for projects unrelated to this work. Dr. Lund has also received honoraria from Teva for projects unrelated to this work. Dr. Kelland has received investigator-initiated funding from Teva Pharmaceutical Industries and Novartis Pharmaceuticals Corporation for projects unrelated to this work. Drs. Rodgers, Stone, Liu, Levy, Kashani and Louie have no industry related conflicts regarding research in multiple sclerosis. Drs. Lund, Kelland, Louie and Rodgers are inventors of U.S. Patent No. 9,623,084.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in these studies involving animals were in accordance with ethical and humane standards set forth by the National Institutes of Health, and with the approval of University of Southern California\u2019s Institutional Animal Care and Use Committee. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}